News
Allergy Tx plots grass pollen jab launch after German okay
Allergy Therapeutics has had its grass pollen allergy treatment Grassmuno approved in Germany, its first market, setting up a launch early next year.
News
Prof Jonathan Benger named as NICE's new CEO
Prof Jonathan Benger will take over from Dr Sam Roberts as CEO of UK reimbursement authority NICE later this week, at a critical time for the agency.
News
Enhertu moves into frontline breast cancer treatment
Daiichi Sankyo and AstraZeneca's Enhertu has become the first new first-line option in the US for HER2-positive breast cancer in more than a decade.
News
J&J claims FDA's latest national priority voucher
The FDA has awarded its latest national priority voucher to Johnson & Johnson for a combination regimen based on Tecvayli for multiple myeloma.
News
Sanofi gets double blow for MS drug tolebrutinib
Shares in Sanofi have slid on a double dose of bad news for its oral BTK inhibitor tolebrutinib, in development as a therapy for multiple sclerosis.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
